Ascendant Dx
Commercialize disruptive diagnostic technologies to aid in diagnosis and treatment of diseases of women and children.
Launch date
Employees
Market cap
-
Enterprise valuation
€7—11m (Dealroom.co estimates May 2014.)
Springdale Arkansas (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.0m | Seed | ||
Total Funding | €1.8m |
Related Content
Recent News about Ascendant Dx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.